Funding tracker
Coherence Neuro raised $45M
$45MRaised
Series AStage
22 Oct 2026Date
128.7KViews on the announcement
The round
| Amount | $45M |
|---|---|
| Stage | Series A |
| Investors | not stated |
| Vertical | Health and bio |
| First reported | Thursday, 22 October 2026 |
The announcement on X
The median tracked announcement from accounts with under 10K followers reached 13.4K views (201 posts). This one did 9.6x that.
We’ve raised a $45m Series A, co-led by @foundersfund and The @OpenAI Startup Fund, to build cancer therapy that learns. Technology is rapidly changing medicine, but data loops and rapid adjustments are still largely missing. When you start cancer treatment, knowing whether what you’re doing is working is too slow. Clearly there is a better way. Build systems to watch cancer in real time, then feed that data into a system that itself can treat the disease. This seeds a future where, unlike drugs, we develop medicine that continuously learns to improve itself. We've been building neurotechnology and BCI platforms to do just that. @coherenceneuro
| Posted by | @WoodingtonBen (Ben Woodington) |
|---|---|
| Followers | 2,138 |
| Views | 128,653 |
| Views per follower | 60x |
| Likes | 759 |
| Reposts | 69 |
| Bookmarks | 302 |
Similar rounds
| Company | Stage | Amount | Lead | On X | Date |
|---|---|---|---|---|---|
| NirvaPendant that only listens to you | Series A | $33M | - | - | 22 Oct 2026 |
| Beyond VisionPortuguese drone maker | Series A | €28M | - | - | 22 Oct 2026 |
| MaveAutomates threat investigations | Series A | $28M | - | - | 22 Oct 2026 |
| Lucid Diagnostics | Series C | $15M | - | - | 22 Oct 2026 |
| IDL | Series A | $15M | - | - | 22 Oct 2026 |
| Firstwork | Series A | $15M | Earlybird Venture Capital | - | 22 Oct 2026 |
Next launch
Planning a launch?
Tell us what is launching and when. Thirty minutes is usually enough to know whether we are the right team for it.